Global Infectious Diseases Diagnostic Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Infectious Diseases Diagnostic Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Infectious-disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized. It can be based solely on clinical presentation or more rigorous diagnostic tests, such as culturing of the infectious agent, microscopy, biochemical screens and molecular methods.

Doctors diagnose infectious diseases using a variety of laboratory tests. Samples of blood, urine, stool, mucus or other body fluids are examined and provide information used in the diagnostic process.

In some cases, doctors identify infectious organisms by examining them under a microscope. Occasionally, laboratories must grow, or culture, the infectious organism from a sample to confirm its presence.

Market Overview:

The latest research study on the global Infectious Diseases Diagnostic market finds that the global Infectious Diseases Diagnostic market reached a value of USD 23117.63 million in 2022. It’s expected that the market will achieve USD 35360.04 million by 2028, exhibiting a CAGR of 7.34% during the forecast period.

Infectious diseases are infectious, epidemic, seasonal and regional. Such as influenza outbreak in winter and spring, malaria outbreak in rainy season; HIV and other infectious diseases are high in some areas, dengue fever and other insect-borne infectious diseases are prevalent in some areas, and viral hepatitis is a heavy burden in some areas. With the progress of society, economy, environment and medicine, the spectrum of infectious diseases is also changing, and some infectious diseases are gradually dying out in some areas. However, new infectious diseases, such as SARS, MERS, Ebola, Zika and COVID-19, will also appear in different periods and places, which increases new market demand. Therefore, the Infectious Diseases Diagnostic market becomes complicated with the emergence and extinction of infectious diseases.

Infectious Diseases Diagnostic Market Drivers

Infectious diseases are the main treatment fields in the global pharmaceutical market. Throughout human history, infectious diseases pose a threat to public health. Because infectious diseases are contagious, they can spread rapidly among a large number of people, causing major public health problems and social and economic burdens.

Infectious diseases are infectious, epidemic, seasonal and regional. Such as influenza outbreak in winter and spring, malaria outbreak in rainy season; HIV and other infectious diseases are high in some areas, dengue fever and other insect-borne infectious diseases are prevalent in some areas, and viral hepatitis is a heavy burden in some areas. With the progress of society, economy, environment and medicine, the spectrum of infectious diseases is also changing, and some infectious diseases are gradually dying out in some areas. However, new infectious diseases, such as SARS, MERS, Ebola, Zika and COVID-19, will also appear in different periods and places, which increases new market demand. Therefore, the Infectious Diseases Diagnostic market becomes complicated with the emergence and extinction of infectious diseases.

Risks of stricter regulation in the industry

In recent years, the entry threshold of Infectious Diseases Diagnostic industry has been relaxed, and many policies at the national level have promoted the industry. This includes shortening the time to market of specific products, and putting products with core technology patents and great clinical value into the priority examination channel. However, many regions put the supervision of product quality in the middle and back end. Therefore, in the Infectious Diseases Diagnostic industry, the ever-changing regulatory pattern or stricter regulation may have a certain impact on the Infectious Diseases Diagnostic market.

Region Overview:

From 2022-2027, Asia-Pacific is estimated to witness robust growth prospects.

Company Overview:

Abbott Laboratories is one of the major players operating in the Infectious Diseases Diagnostic market, holding a share of 18.56% in 2021.

Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products.

Roche Diagnostics

Roche Diagnostics Ltd. develops and manufactures medical and diagnostic products. The Company produces self-monitoring systems, applications, testing, coagulation, and instruments for critical-care, cardiovascular, liver diseases, cancer, and tuberculosis.

Segmentation Overview:

Among different product types, Blood segment is anticipated to contribute the largest market share in 2027.

Doctors may arrange appropriate ways (such as Laboratory tests or Imaging scans) to perform Infectious Diseases Diagnostic to help determine the cause and customize the treatment plan. Body fluid can sometimes reveal the evidence of specific microorganisms causing diseases, which is one of the most common Infectious Diseases Diagnostic methods. Urine and Blood are the two most common methods.

Blood: Technicians get blood samples by inserting needles into veins (usually in arms).

Urine: This painless test requires the testee to put urine in a container. In order to avoid potential contamination of samples, subjects may be required to clean your genital area with a disinfectant pad and collect urine in the middle.

Others mainly include Throat swabs, Stool sample, etc.

Application Overview:

The market's largest segment by application is the segment Hospitals and Trauma Centers, with a market share of 45.52% in 2021.

Key Companies in the global Infectious Diseases Diagnostic market covered in Chapter 3:

Abbott Laboratories
DiaSorin S.p.A.
Siemens Healthineers AG
bioMerieux SA
Roche Diagnostics
Bio-Rad Laboratories, Inc.
QIAGEN
Hologic, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Grifols SA
Becton Dickinson & Company
Quidel Corporation

In Chapter 4 and Chapter 14.2, on the basis of types, the Infectious Diseases Diagnostic market from 2018 to 2029 is primarily split into:

Urine
Blood
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Infectious Diseases Diagnostic market from 2018 to 2029 covers:

Hospitals and Trauma Centers
Diagnostic Laboratories
Rehabilitation Centers
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)